 | • レポートコード：MRC23Q36335 • 出版社/出版日：QYResearch / 2023年3月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥420,500 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥841,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のRNA等温増幅技術市場について調査・分析し、世界のRNA等温増幅技術市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（エンドポイント法、リアルタイム蛍光検出）、用途別セグメント分析（感染検知分野、腫瘍検知分野、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、HOLOGIC、Becton、BioHelix Corporation、BioMerieux Biotechnology Company、Thermo Fisher、Wuhan Zhongzhi Biotechnology、Shanghai Rendu Biotechnology、Shengxiang Biotechnology、Shanghai Liferiver、Jiangsu Shuoshi Biotechnology Co., Ltd.、AmoyDxなどが含まれています。世界のRNA等温増幅技術市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、RNA等温増幅技術市場規模を推定する際に考慮しました。本レポートは、RNA等温増幅技術の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、RNA等温増幅技術に関するビジネス上の意思決定に役立てることを目的としています。 ・RNA等温増幅技術市場の概要 - RNA等温増幅技術のタイプ別セグメント - 世界のRNA等温増幅技術市場規模：タイプ別分析（エンドポイント法、リアルタイム蛍光検出） - RNA等温増幅技術の用途別セグメント - 世界のRNA等温増幅技術市場規模：用途別分析（感染検知分野、腫瘍検知分野、その他） - 世界のRNA等温増幅技術市場規模予測（2018年-2029年） ・RNA等温増幅技術市場の成長トレンド - RNA等温増幅技術の地域別市場規模（2018年-2029年） - RNA等温増幅技術市場ダイナミクス - RNA等温増幅技術の業界動向 - RNA等温増幅技術市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：エンドポイント法、リアルタイム蛍光検出 - 世界のRNA等温増幅技術のタイプ別市場規模（2018年-2023年） - 世界のRNA等温増幅技術のタイプ別市場規模（2024年-2029年） ・用途別セグメント：感染検知分野、腫瘍検知分野、その他 - 世界のRNA等温増幅技術の用途別市場規模（2018年-2023年） - 世界のRNA等温増幅技術の用途別市場規模（2024年-2029年） ・RNA等温増幅技術の地域別市場規模 - 北米のRNA等温増幅技術市場規模（2018年-2029年） - アメリカのRNA等温増幅技術市場規模（2018年-2029年） - ヨーロッパのRNA等温増幅技術市場規模（2018年-2029年） - アジア太平洋のRNA等温増幅技術市場規模（2018年-2029年） - 中国のRNA等温増幅技術市場規模（2018年-2029年） - 日本のRNA等温増幅技術市場規模（2018年-2029年） - 韓国のRNA等温増幅技術市場規模（2018年-2029年） - インドのRNA等温増幅技術市場規模（2018年-2029年） - オーストラリアのRNA等温増幅技術市場規模（2018年-2029年） - 中南米のRNA等温増幅技術市場規模（2018年-2029年） - 中東・アフリカのRNA等温増幅技術市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 HOLOGIC、Becton、BioHelix Corporation、BioMerieux Biotechnology Company、Thermo Fisher、Wuhan Zhongzhi Biotechnology、Shanghai Rendu Biotechnology、Shengxiang Biotechnology、Shanghai Liferiver、Jiangsu Shuoshi Biotechnology Co., Ltd.、AmoyDx ・アナリストの観点/結論 ・調査方法とデータソース |
RNA isothermal amplification technology is a molecular biology technology used to amplify specific RNA fragments. Its main technical principle is to first generate a double-stranded DNA copy of the target nucleic acid (RNA) by reverse transcriptase at the same temperature. , and then use RNA polymerase to generate multiple RNA copies from the DNA copy; sometimes, each newly generated RNA copy can also enter the next cycle from reverse transcription; to achieve the purpose of exponentially amplifying RNA.
Highlights
The global RNA Isothermal Amplification Technology market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for RNA Isothermal Amplification Technology is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for RNA Isothermal Amplification Technology is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for RNA Isothermal Amplification Technology in Infection Detection Field is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of RNA Isothermal Amplification Technology include HOLOGIC, Becton, BioHelix Corporation, BioMerieux Biotechnology Company, Thermo Fisher, Wuhan Zhongzhi Biotechnology, Shanghai Rendu Biotechnology, Shengxiang Biotechnology and Shanghai Liferiver, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for RNA Isothermal Amplification Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Isothermal Amplification Technology.
The RNA Isothermal Amplification Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global RNA Isothermal Amplification Technology market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNA Isothermal Amplification Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
HOLOGIC
Becton
BioHelix Corporation
BioMerieux Biotechnology Company
Thermo Fisher
Wuhan Zhongzhi Biotechnology
Shanghai Rendu Biotechnology
Shengxiang Biotechnology
Shanghai Liferiver
Jiangsu Shuoshi Biotechnology Co., Ltd.
AmoyDx
Segment by Type
Endpoint Method
Real-time Fluorescence detection
Segment by Application
Infection Detection Field
Tumor Detection Field
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNA Isothermal Amplification Technology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA Isothermal Amplification Technology Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Endpoint Method
1.2.3 Real-time Fluorescence detection
1.3 Market by Application
1.3.1 Global RNA Isothermal Amplification Technology Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Infection Detection Field
1.3.3 Tumor Detection Field
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNA Isothermal Amplification Technology Market Perspective (2018-2029)
2.2 RNA Isothermal Amplification Technology Growth Trends by Region
2.2.1 Global RNA Isothermal Amplification Technology Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 RNA Isothermal Amplification Technology Historic Market Size by Region (2018-2023)
2.2.3 RNA Isothermal Amplification Technology Forecasted Market Size by Region (2024-2029)
2.3 RNA Isothermal Amplification Technology Market Dynamics
2.3.1 RNA Isothermal Amplification Technology Industry Trends
2.3.2 RNA Isothermal Amplification Technology Market Drivers
2.3.3 RNA Isothermal Amplification Technology Market Challenges
2.3.4 RNA Isothermal Amplification Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA Isothermal Amplification Technology Players by Revenue
3.1.1 Global Top RNA Isothermal Amplification Technology Players by Revenue (2018-2023)
3.1.2 Global RNA Isothermal Amplification Technology Revenue Market Share by Players (2018-2023)
3.2 Global RNA Isothermal Amplification Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by RNA Isothermal Amplification Technology Revenue
3.4 Global RNA Isothermal Amplification Technology Market Concentration Ratio
3.4.1 Global RNA Isothermal Amplification Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA Isothermal Amplification Technology Revenue in 2022
3.5 RNA Isothermal Amplification Technology Key Players Head office and Area Served
3.6 Key Players RNA Isothermal Amplification Technology Product Solution and Service
3.7 Date of Enter into RNA Isothermal Amplification Technology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA Isothermal Amplification Technology Breakdown Data by Type
4.1 Global RNA Isothermal Amplification Technology Historic Market Size by Type (2018-2023)
4.2 Global RNA Isothermal Amplification Technology Forecasted Market Size by Type (2024-2029)
5 RNA Isothermal Amplification Technology Breakdown Data by Application
5.1 Global RNA Isothermal Amplification Technology Historic Market Size by Application (2018-2023)
5.2 Global RNA Isothermal Amplification Technology Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America RNA Isothermal Amplification Technology Market Size (2018-2029)
6.2 North America RNA Isothermal Amplification Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America RNA Isothermal Amplification Technology Market Size by Country (2018-2023)
6.4 North America RNA Isothermal Amplification Technology Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNA Isothermal Amplification Technology Market Size (2018-2029)
7.2 Europe RNA Isothermal Amplification Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe RNA Isothermal Amplification Technology Market Size by Country (2018-2023)
7.4 Europe RNA Isothermal Amplification Technology Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNA Isothermal Amplification Technology Market Size (2018-2029)
8.2 Asia-Pacific RNA Isothermal Amplification Technology Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific RNA Isothermal Amplification Technology Market Size by Region (2018-2023)
8.4 Asia-Pacific RNA Isothermal Amplification Technology Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNA Isothermal Amplification Technology Market Size (2018-2029)
9.2 Latin America RNA Isothermal Amplification Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America RNA Isothermal Amplification Technology Market Size by Country (2018-2023)
9.4 Latin America RNA Isothermal Amplification Technology Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA Isothermal Amplification Technology Market Size (2018-2029)
10.2 Middle East & Africa RNA Isothermal Amplification Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa RNA Isothermal Amplification Technology Market Size by Country (2018-2023)
10.4 Middle East & Africa RNA Isothermal Amplification Technology Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 HOLOGIC
11.1.1 HOLOGIC Company Detail
11.1.2 HOLOGIC Business Overview
11.1.3 HOLOGIC RNA Isothermal Amplification Technology Introduction
11.1.4 HOLOGIC Revenue in RNA Isothermal Amplification Technology Business (2018-2023)
11.1.5 HOLOGIC Recent Development
11.2 Becton
11.2.1 Becton Company Detail
11.2.2 Becton Business Overview
11.2.3 Becton RNA Isothermal Amplification Technology Introduction
11.2.4 Becton Revenue in RNA Isothermal Amplification Technology Business (2018-2023)
11.2.5 Becton Recent Development
11.3 BioHelix Corporation
11.3.1 BioHelix Corporation Company Detail
11.3.2 BioHelix Corporation Business Overview
11.3.3 BioHelix Corporation RNA Isothermal Amplification Technology Introduction
11.3.4 BioHelix Corporation Revenue in RNA Isothermal Amplification Technology Business (2018-2023)
11.3.5 BioHelix Corporation Recent Development
11.4 BioMerieux Biotechnology Company
11.4.1 BioMerieux Biotechnology Company Company Detail
11.4.2 BioMerieux Biotechnology Company Business Overview
11.4.3 BioMerieux Biotechnology Company RNA Isothermal Amplification Technology Introduction
11.4.4 BioMerieux Biotechnology Company Revenue in RNA Isothermal Amplification Technology Business (2018-2023)
11.4.5 BioMerieux Biotechnology Company Recent Development
11.5 Thermo Fisher
11.5.1 Thermo Fisher Company Detail
11.5.2 Thermo Fisher Business Overview
11.5.3 Thermo Fisher RNA Isothermal Amplification Technology Introduction
11.5.4 Thermo Fisher Revenue in RNA Isothermal Amplification Technology Business (2018-2023)
11.5.5 Thermo Fisher Recent Development
11.6 Wuhan Zhongzhi Biotechnology
11.6.1 Wuhan Zhongzhi Biotechnology Company Detail
11.6.2 Wuhan Zhongzhi Biotechnology Business Overview
11.6.3 Wuhan Zhongzhi Biotechnology RNA Isothermal Amplification Technology Introduction
11.6.4 Wuhan Zhongzhi Biotechnology Revenue in RNA Isothermal Amplification Technology Business (2018-2023)
11.6.5 Wuhan Zhongzhi Biotechnology Recent Development
11.7 Shanghai Rendu Biotechnology
11.7.1 Shanghai Rendu Biotechnology Company Detail
11.7.2 Shanghai Rendu Biotechnology Business Overview
11.7.3 Shanghai Rendu Biotechnology RNA Isothermal Amplification Technology Introduction
11.7.4 Shanghai Rendu Biotechnology Revenue in RNA Isothermal Amplification Technology Business (2018-2023)
11.7.5 Shanghai Rendu Biotechnology Recent Development
11.8 Shengxiang Biotechnology
11.8.1 Shengxiang Biotechnology Company Detail
11.8.2 Shengxiang Biotechnology Business Overview
11.8.3 Shengxiang Biotechnology RNA Isothermal Amplification Technology Introduction
11.8.4 Shengxiang Biotechnology Revenue in RNA Isothermal Amplification Technology Business (2018-2023)
11.8.5 Shengxiang Biotechnology Recent Development
11.9 Shanghai Liferiver
11.9.1 Shanghai Liferiver Company Detail
11.9.2 Shanghai Liferiver Business Overview
11.9.3 Shanghai Liferiver RNA Isothermal Amplification Technology Introduction
11.9.4 Shanghai Liferiver Revenue in RNA Isothermal Amplification Technology Business (2018-2023)
11.9.5 Shanghai Liferiver Recent Development
11.10 Jiangsu Shuoshi Biotechnology Co., Ltd.
11.10.1 Jiangsu Shuoshi Biotechnology Co., Ltd. Company Detail
11.10.2 Jiangsu Shuoshi Biotechnology Co., Ltd. Business Overview
11.10.3 Jiangsu Shuoshi Biotechnology Co., Ltd. RNA Isothermal Amplification Technology Introduction
11.10.4 Jiangsu Shuoshi Biotechnology Co., Ltd. Revenue in RNA Isothermal Amplification Technology Business (2018-2023)
11.10.5 Jiangsu Shuoshi Biotechnology Co., Ltd. Recent Development
11.11 AmoyDx
11.11.1 AmoyDx Company Detail
11.11.2 AmoyDx Business Overview
11.11.3 AmoyDx RNA Isothermal Amplification Technology Introduction
11.11.4 AmoyDx Revenue in RNA Isothermal Amplification Technology Business (2018-2023)
11.11.5 AmoyDx Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
| 【RNA等温増幅技術について】 ※RNA等温増幅技術は、特定のRNA分子を効率的に増幅するための方法論です。この技術は、従来のPCR（ポリメラーゼ連鎖反応）などの増幅手法に比べて、特に温度変化に依存しないという特性を持っています。これにより、よりシンプルな装置で実施可能であり、短時間で結果を得ることができます。 この技術の基本的な定義は、等温条件下でRNAを特異的に増幅する過程です。RNAの特異的な配列領域を認識し、それを増幅するためのプローブやプリマーを用います。一般的なRNA増幅方法と比較して、必要な温度管理が緩和され、環境条件がより穏やかなため、さまざまな環境で使用できるというメリットがあります。 RNA等温増幅技術の特徴としては、いくつかのポイントがあります。まず第一に、等温で実施されるため、専用の熱サイクラーが不要です。このため、現場での実施が容易で、生物学的試料の処理や分析が迅速に行えます。また、増幅効率が高いため、少量のRNAサンプルからも短時間で大量のコピーを得ることが可能です。さらに、この技術は特異性が高く、目的とするRNAに対して高い感度を発揮します。 RNA等温増幅技術には、いくつかの具体的な種類があります。その中でも代表的なものに、LAMP（ループ媒介等温増幅法）、RPA（超速逆転写ポリメラーゼ連鎖反応）、NASBA（核酸標識増幅法）、TMA（転写媒介増幅法）があります。これらの手法は、それぞれ異なるメカニズムを持ち、特定の研究ニーズに応じて使い分けることができます。たとえば、LAMPは特異的なループ構造を形成し、非常に高い増幅速度を実現する一方で、RPAはサンプル内のRNAに迅速に反応し、NAT（核酸酸化技術）をせずに増幅を行います。 RNA等温増幅技術の用途は多岐にわたります。これらの手法は主に診断の分野で利用されており、感染症の検査やウイルス検出、さらに癌細胞の特定や遺伝子異常の同定にも応用されています。特にCOVID-19パンデミック以降、SARS-CoV-2ウイルスのRNAを検出するための手法としてLAMPが注目され、迅速かつ簡便な検査法として広まりました。また、農業分野でも植物病害の早期診断や、特定の病原体の検出に利用されています。 関連技術としては、次世代シーケンシング（NGS）やCRISPR/Cas技術があります。NGSはRNAを高解像度でシーケンスする能力を持ち、RNA等温増幅技術と組み合わせることで、より詳細な解析を行うことが可能です。一方、CRISPR技術はRNAを特異的に認識する能力を持ち、RNA増幅技術と相互作用することで、ターゲットRNAの特定や検出を高感度で実施できる可能性があります。これらの技術が相まることで、RNAの解析や生物学的研究がより効率的に進められるようになります。 最後に、RNA等温増幅技術はその柔軟さと高感度から、今後さらに多くの研究分野で活用されることが期待されます。これにより、より迅速で信頼性の高い診断方法が確立され、医療やバイオテクノロジーの発展に寄与することでしょう。 |
